COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,708 Articles (22,913 medRxiv, 8,795 bioRxiv)

Most recent first Previous |  Page 1421: Articles 14201-14210  | Next

Modeling COVID-19 vaccine efficacy and coverage towards herd-immunity in the Basque Country, Spain
Stollenwerk, N., Mar, J., Bidaurrazaga Van-Dierdonck, J., Ibarrondo, O., Estadilla, C., Aguiar, M.
10.1101/2021.07.12.21260390 — Posted: 2021-07-15
Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
Chau, C. V. V., Nhan, L. N. T., Nguyet, L. A., Tu, N. T. K., Hong, N. T. T., Man, D. N. H., Ty, D. T. B., Nhu, L. N. T., Yen, L. M., Khanh, T. H., Minh, N. N. Q., Ny, N. T. H., Anderson, D., Wang, L.-F., van Doorn, H. R., Hung, N. T., Thanh, T. T., Thwaites, G., Tan, L. V.
10.1101/2021.07.12.21260379 — Posted: 2021-07-15
Quantifying social contact patterns in Minnesota during Stay-at-Home social distancing order
Dorelien, A. M., Venkateswaran, N., Deng, J., Searle, K., Enns, E., Kulasingam, S.
10.1101/2021.07.12.21260216 — Posted: 2021-07-15
COVID-19 Pandemic Analysis
van Lint, V. A. J.
10.1101/2021.07.12.21260326 — Posted: 2021-07-15
DNR order in SARS-CoV-2 patients: preliminary guidelines validation and quality of palliative care in a single Swiss COVID-19 Center.
Lo Presti, G., Biggiogero, M., Glotta, A., Biondi, C., Horvath, Z., Leo, R., Franzetti-Pellanda, A., Saporito, A., Ceruti, S., Capdevila, X.
10.1101/2021.07.12.21260359 — Posted: 2021-07-15
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders
Antonucci, p., fiore, j. R., de feo, l., granato, t., distefano, m., faleo, g., farhan, a. m., margaglione, m., centra, m., santantonio, t. a.
10.1101/2021.07.12.21260358 — Posted: 2021-07-15
Factors associated with transmission in COVID-19 outbreaks in long-term care facilities
Vijh, R., Ng, C. H., Shirmaleki, M., Bharmal, A.
10.1101/2021.07.12.21260345 — Posted: 2021-07-15
Conversion rate to the secondary conformation state in the binding mode of SARS-CoV-2 spike protein to human ACE2 may predict infectivity efficacy of the underlying virus mutant
Sevenich, M., van den Heuvel, J., Gering, I., Mohrlueder, J., Willbold, D.
10.1101/2021.07.14.452313 — Posted: 2021-07-14
Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase
Pacl, H. T., Tipper, J. L., Sevalkar, R. R., Crouse, A., Crowder, C., UAB Precision Medicine Institute, , Holder, G. D., Kuhlman, C. J., Chinta, K. C., Nadeem, S., Green, T. J., Petit, C. M., Steyn, A. J., Might, M., Harrod, K. S.
10.1101/2021.07.13.449251 — Posted: 2021-07-14
Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets
Haid, S., Matthaei, A., Winkler, M., Sake, S. M., Gunesch, A. P., Rueckert, J., Vieyres, G., Kuehl, D., Nguyen, T.-T., Lasswitz, L., Zapatero, F., Brogden, G., Gerold, G., Wiegmann, B., Bilitewski, U., Broenstrup, M., Schulz, T., Pietschmann, T.
10.1101/2021.07.14.452343 — Posted: 2021-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).